Healthy volunteers test two forms of experimental drug
NCT ID NCT03340753
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study compared two versions (tablet vs capsule) of the experimental drug KBP-5074 in 20 healthy adults. The goal was to see how the body absorbs each form and whether they work similarly. Results will help choose the right dose for future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- KBP-5074
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medpace CLinical Pharmacology
Cincinnati, Ohio, 45227, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.